LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Turbine Simulated Cell Technologies Ltd.
Headquarters:
Budapest, Hungary
Website:
http://www.turbine.ai
Year Founded:
2016
Status:
Private
BioCentury
|
Apr 2, 2024
Deals
Deals report: Abingworth and Blackstone bet on late-stage programs
Plus: Gilead acquires Xilio’s IL-12 program and Harmonic-Turbine to co-develop dark kinase therapy for cancer
Read More
BioCentury
|
Sep 29, 2023
Management Tracks
Novartis veteran Fox to head Teva’s U.S. commercial business
Plus: Rich Scott succeeding Chris Wigley at Genomics England, and updates from Sonoma, PIC, Turbine and LCRF
Read More
BioCentury
|
Jun 21, 2023
Deals
June 20 Quick Takes: FDA approves argenx’s subcutaneous Vyvgart
Plus: Clozel provides Idorsia cash lifeline, a clinical hold for Arcellx and updates from Vera, Denali, Delve Bio and Turbine
Read More
BioCentury
|
Nov 22, 2022
Finance
Nov. 22 Quick Takes: Brandon, Jeito lead €50M round for CatalYm
Plus Arvinas falls on protein degradation data and updates from Turbine, GSK, argenx and more
Read More
Items per page:
10
1 - 4 of 4